You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Thank you for awesome work and sharing it in very detailed manner.
I however think that the A20 antibody neutralization assay has an issue with the calculation of antibody selection. The selection in the paper is s = fab/fv but your calculation did not account for the variability of infectivity of different mutants. If you normalize with fv (frequency of the viral packaging), you are assuming that every mutant infects HEK293 at the same rate, which is absolutely not the case, especially with the mutation in the variable regions.
So I would propose this selection formula instead: s = f_withA20 / f_withoutA20 where f is the frequency found in the cells after infection.
I hope this might contribute somehow to your work.
Best regards,
Ai
The text was updated successfully, but these errors were encountered:
Thanks Ai for your suggestion! We agree what you propose seems to be a
reasonable approach and an improvement on our initial calculation, provided
that the variants which do not infect at all are somehow masked out. -Eric
On Tue, Apr 19, 2022 at 8:54 AM Ai Vu Hong ***@***.***> wrote:
Dear authors,
Thank you for awesome work and sharing it in very detailed manner.
I however think that the A20 antibody neutralization assay has an issue
with the calculation of antibody selection. The selection in the paper is s
= fab/fv but your calculation did not account for the variability of
infectivity of different mutants. If you normalize with fv (frequency of
the viral packaging), you are assuming that every mutant infects HEK293 at
the same rate, which is absolutely not the case, especially with the
mutation in the variable regions.
So I would propose this selection formula instead: s = f_withA20 /
f_withoutA20 where f is the frequency found in the cells after infection.
I hope this might contribute somehow to your work.
Best regards,
Ai
—
Reply to this email directly, view it on GitHub
<#3>, or
unsubscribe
<https://github.com/notifications/unsubscribe-auth/AAPL5YKXYSRIYL7YAIJQB5TVF2UHPANCNFSM5TYYBV4A>
.
You are receiving this because you are subscribed to this thread.Message
ID: ***@***.***>
Dear authors,
Thank you for awesome work and sharing it in very detailed manner.
I however think that the A20 antibody neutralization assay has an issue with the calculation of antibody selection. The selection in the paper is s = fab/fv but your calculation did not account for the variability of infectivity of different mutants. If you normalize with fv (frequency of the viral packaging), you are assuming that every mutant infects HEK293 at the same rate, which is absolutely not the case, especially with the mutation in the variable regions.
So I would propose this selection formula instead: s = f_withA20 / f_withoutA20 where f is the frequency found in the cells after infection.
I hope this might contribute somehow to your work.
Best regards,
Ai
The text was updated successfully, but these errors were encountered: